Low-level ALK copy number gain is relatively common in some tumor types, e.g., in alveolar rhabdomyosarcoma [34, 35], in NSCLC [36], and in up to 10% of renal cell carcinomas [37]. This evidence concerns the gene ALK and neoplasm.